Author:
Rhea Elizabeth M.,Leclerc Manon,Yassine Hussein N.,Capuano Ana W.,Tong Han,Petyuk Vladislav A.,Macauley Shannon L.,Fioramonti Xavier,Carmichael Owen,Calon Frederic,Arvanitakis Zoe
Subject
Cell Biology,Neurology (clinical),Geriatrics and Gerontology,Pathology and Forensic Medicine
Reference341 articles.
1. Collaborators GBDDF (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 7:e105-e125.
2. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract, 157:107843.
3. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004). Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol, 61:661-666.
4. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 396:413-446.
5. Sato N, Morishita R (2014). Brain alterations and clinical symptoms of dementia in diabetes: abeta/tau-dependent and independent mechanisms. Front Endocrinol (Lausanne), 5:143.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献